The role of IGF-1 and Ghrelin in the compensation of intrauterine growth restriction

Reproductive Sciences

Volumn 16, Issue 12, 2009, Pages 1193-1200

  Kyriakakou, Marialena ^a   Malamitsi Puchner, Ariadne ^a   Mastorakos, George ^a   Boutsikou, Theodora ^a   Hassiakos, Demetrios ^a   Papassotiriou, Ioannis ^b   Kanaka Gantenbein, Christina ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Ghrelin; IGF I; Intrauterine growth restriction; IUGR.

Indexed keywords

GHRELIN; HYDROCORTISONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEWBORN; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; BIRTH WEIGHT; CASE-CONTROL STUDIES; ENERGY METABOLISM; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; GHRELIN; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; PREGNANCY; TIME FACTORS; YOUNG ADULT;

EID: 70450205240     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719109344629     Document Type: Article

References (46)

1. Barker DJ The origins of the developmental origins theory. J Intern Med. 2007 ; 261 (5). 412-417.
2. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993 ; 341 (8850). 938-941.
3. Wollmann HA Intrauterine growth restriction: definition and etiology. Horm Res. 1998 ; 49 (suppl 2). 1-6.
4. Mamelle N., Cochet V., Claris O. Definition of fetal growth restriction according to constitutional growth potential. Biol Neonate. 2001 ; 80 (4). 277-285.
5. Saenger P., Czernichow P., Hughes I., Reiter EO Small for gestational age: short stature and beyond. Endocr Rev. 2007 ; 28 (2). 219-251.
6. Monk D., Moore GE Intrauterine growth restriction- genetic causes and consequences. Semin Fetal Neonatal Med. 2004 ; 9 (5). 371-378.
7. Bamberg C., Kalache KD Prenatal diagnosis of fetal growth restriction. Semin Fetal Neonatal Med. 2004 ; 9 (5). 387-394.
8. Hales CN, Barker DJ The thrifty phenotype hypothesis. Br Med Bull. 2001 ; 60: 5-20.
9. Gluckman PD, Hanson MA, Cooper C., Thornburg KL Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008 ; 359 (1). 61-73.
10. Desai M., Babu J., Ross MG Programmed metabolic syndrome: prenatal undernutrition and postweaning overnutrition. Am J Physiol Regul Integr Comp Physiol. 2007 ; 293 (6). R2306 - R2314.
11. Fowden AL The insulin-like growth factors and fetoplacental growth. Placenta. 2003 ; 24 (8-9). 803-812.
12. Gicquel C., Le Bouc Y. Hormonal regulation of fetal growth. Horm Res. 2006 ; 65 (suppl 3). 28-33.
13. Randhawa RS The insulin-like growth factor system and fetal growth restriction. Pediatr Endocrinol Rev. 2008 ; 6 (2). 235-240.
14. Giudice LC, de Zegher F., Gargosky SE, et al. Insulin-like growth factors and their binding proteins in the term and pre-term human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 1995 ; 80 (5). 1548-1555.
15. Holt RI Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab. 2002 ; 13 (9). 392-397.
16. Klammt J., PfCurrency signffle R., Werner H., Kiess W. IGF signaling defects as causes of growth failure and IUGR. Trends Endocrinol Metab. 2008 ; 19 (6). 197-205.
17. Styne D. Growth. In: Gardner GD, Shoback D, eds. Greenspanĝ€ ™s Basic and Clinical Endocrinology. 8 th ed. New York, NY: Lange Medical Books / McGraw-Hill ; 2007: 171-180.
18. Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab. 2001 ; 12 (3). 118-122. (Pubitemid 33714199)
19. Ghigo E., Broglio F., Arvat E., Maccario M., Papotti M., Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf). 2005 ; 62 (1). 1-17.
20. Date Y., Nakazato M., Hashiguchi S., et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 2002 ; 51 (1). 124-129.
21. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001 ; 86 (12). 5992-5993.
22. Hosoda H., Kojima M., Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci. 2006 ; 100 (5). 398-410.
23. Egido EM, Rodriguez-Gallardo J., Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol. 2002 ; 146 (2). 241-244.
24. Cortelazzi D., Cappiello V., Morpurgo PS, et al. Circulating levels of ghrelin in human fetuses. Eur J Endocrinol. 2003 ; 149 (2). 111-116. (Pubitemid 36987152)
25. Gardosi J., Chang A., Kaylan B., Sahota D., Symonds EM Customised antenatal growth charts. Lancet. 1992 ; 339 (8788). 283-287.
26. Gardosi J. Customized fetal growth standards: rationale and clinical application. Semin Perinatol. 2004 ; 28 (1). 33-40.
27. Kyriakakou M., Malamitsi-Puchner A., Militsi H., et al. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers. Eur J Endocrinol. 2008 ; 158 (3). 343-348.
28. Ozkan H., Aydin A., Demir N., Erci T., büyükgebiz A. Associations of IGF-I, IGFBP-1 and IGFBP-3 on intrauterine growth and early catch-up growth. Biol Neonate. 1999 ; 76 (5). 274-282.
29. Fu Q., Yu X., Callaway CW, Lane RH, McKnight RA Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J. 2009 ; 23 (8). 2438-2449.
30. Leger J., Noel M., Limal JM, Czernichow P., and the Study Group of IUGR. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Pediatr Res. 1996 ; 40 (1). 101-107.
31. Verkauskiene R., Beltrand J., Claris O., et al. Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age. Eur J Endocrinol. 2007 ; 157 (5). 605-612.
32. Cutfield WS, Hofman PL, Vickers M., Breier B., Blum WF, Robinson EM IGFs and binding proteins in short children with intrauterine growth retardation. J Clin Endocrinol Metab. 2002 ; 87 (1). 235-239.
33. Cianfarani S., Germani D., Rossi L., et al. IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood. Eur J Endocrinol. 1998 ; 138 (5). 524-529.
34. Swolin D., Brantsing C., Matejka G., Ohlsson C. Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. J Endocrinol. 1996 ; 149 (3). 397-403.
35. Soriano-Guillén L., Barrios V., Chowen JA, et al. Ghrelin levels from fetal life through early adulthood: relationship with endocrine and metabolic and anthropometric measures. J Pediatr. 2004 ; 144 (1). 30-35.
36. I±iguez G., Ong K., Pe±a V., Avila A., Dunger D., Mericq V. Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age. J Clin Endocrinol Metab. 2002 ; 87 (12). 5830-5833.
37. Farquhar J., Heiman M., Wong AC, Wach R., Chessex P., Chanoine JP Elevated umbilical cord ghrelin concentrations in small for gestational age neonates. J Clin Endocrinol Metab. 2003 ; 88 (9). 4324-4327.
38. Bellone S., Rapa A., Vivenza D., et al. Circulating ghrelin levels in the newborn are positively associated with gestational age. Clin Endocrinol. (Oxf). 2004 ; 60 (5). 613-617.
39. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev. 2006 ; 27 (2). 101-140.
40. Martínez-Cordero C., Amador-Licona N., Guízar-Mendoza JM, Hernández-Méndez J., Ruelas-Orozco G. Body fat at birth and cord blood levels of insulin, adiponectin, leptin, and insulin-like growth factor-I in small-for-gestational-age infants. Arch Med Res. 2006 ; 37 (4). 490-494.
41. Street ME, Volta C., Ziveri MA, Viani I., Bernasconi S. Markers of insulin sensitivity in placentas and cord serum of intrauterine growth restricted (IUGR) newborns. Clin Endocrinol (Oxf). 2009 [Epub ahead of print].
42. Wang X., Cui Y., Tong X., Ye H., Li S. Glucose and lipid metabolism in small-for-gestational-age infants at 72 hours of age. J Clin Endocrinol Metab. 2007 ; 92 (2). 681-684.
43. Beltrand J., Nicolescu R., Kaguelidou F., et al. Catch-up growth following fetal growth restriction promotes rapid restoration of fat mass but without metabolic consequences at one year of age. PLoS One. 2009 ; 4 (4). e5343.
44. Mericq V., Ong KK, Bazaes R., et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia. 2005 ; 48 (12). 2609-2614.
45. Jaquet D., Deghmoun S., Chevenne D., Collin D., Czernichow P., Lévy-Marchal C. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia. 2005 ; 48 (5). 849-855. (Pubitemid 40767976)
46. Cianfarani S., Maiorana A., Geremia C., Scirè G., Spadoni GL, Germani D. Blood glucose concentrations are reduced in children born small for gestational age (SGA), and thyroid-stimulating hormone levels are increased in SGA with blunted postnatal catch-up growth. J Clin Endocrinol Metab. 2003 ; 88 (6). 2699-2705.